Inventory and Assessment: Healthcare System’s Oncology Data Assets
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
Comprehensive Inventory & Assessment of Integrated Health System’s Oncology Data
Matt Zuga, High Cape
“RNA is my go to firm for diligence, modeling and valuation projects. Responsive…check, reliable…check, understand my investments and companies…check.”
Market Assessment: Biopharma Company
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
Early-Stage Biopharma Company Needs Strategy and Research Support to Inform Prioritization
Kevin Slawin, Rapha Capital PE
“As the founder of Rapha Capital, an investment advisory, as well as the founder and/or board member of multiple private-stage companies in the biotech and medtech arenas, I’ve worked with RNA in many capacities, including target identification, diligence and in transaction advisory capacities. They are my “go to” firm to help me with all of […]
Buy-Side Due Diligence: Organ on a Chip
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
Buy-side Due Diligence Support for a Potential Investor
Fairness Opinion: General Partner-led Secondary Transaction
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
Royalty Fund Seeks to Make a Final Distribution to Limited Partners
Fairness Opinion: SPAC Target Company Valuation in Biotech
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
SPAC Seeks Target Company Valuation in Merger Consideration Transaction
Fairness Opinion: De-SPAC Transaction for Inflammatory Disorders Therapeutics Company
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
SPAC Seeks Independent Valuation of Target
Fairness Opinion: De-SPAC Transaction for T-Cell Therapeutics Company
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
SPAC Seeks Independent Valuation of Target Company in T-Cell Therapeutics
Fairness Opinion: De-SPAC Transaction for Private Biotech Company
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
SPAC Seeks Independent Valuation of Target in Mental Health Disorders